Template:Hyperlipoproteinemia: Difference between revisions

Lipoprotein Disorders Main Page
	Hyperlipoproteinemia Microchapters
Hypercholesterolemia Patient Information
Hypertriglyceridemia Patient Information
Overview
Classification Familial hyperchylomicronemia Familial hypercholesterolemia Familial combined hyperlipidemia Dysbetalipoproteinemia Primary hypertriglyceridemia Mixed hyperlipoproteinemia
Differential Diagnosis
Screening
ACC/AHA Guideline Recommendations
Summary
Treatment
Major recommendations for statin therapy
Therapeutic response to statin therapy
Blood cholesterol LDL and non-HDL treatment goals
Treatment in heart failure and hemodialysis
Primary prevention
Secondary prevention
Intensity of statin therapy in primary and secondary prevention
Safety Recommendations
Guideline on Lifestyle Management

VisualWikitext

@@ Line 1: / Line 1: @@
 {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
+|- bgcolor="LightGrey"
+!
+[[Lipoprotein disorders| Lipoprotein Disorders Main Page]]
 |-
 | colspan="1" style="text-align:center; background:DarkGray" |
@@ Line 6: / Line 11: @@
 |- bgcolor="LightGrey"
+|- bgcolor="Pink"
+!
+[[Hypercholesterolemia (patient information)|Hypercholesterolemia Patient Information]]
+|-
 !
-|- bgcolor="Coral"
+|- bgcolor="Pink"
 !
-[[Lipid disorders|Lipid Disorders Main Page]]
+[[Hypertriglyceridemia (patient information)|Hypertriglyceridemia Patient Information]]
 |-
 !
-|- bgcolor="LightCoral"
+|- bgcolor="Pink"
 !
-[[Hypolipoproteinemia|Hypolipoproteinemia Main Page]]
+[[Hyperlipoproteinemia#Overview|Overview]]
 |-
 !
@@ Line 21: / Line 32: @@
 |- bgcolor="Pink"
 !
-[[Hyperlipoproteinemia (patient information)|Patient Information]]
+[[Hyperlipoproteinemia#Classification|Classification]]
+:'''[[Familial hyperchylomicronemia]]'''
+:'''[[Familial hypercholesterolemia]]'''
+:'''[[Familial combined hyperlipidemia]]'''
+:'''[[Dysbetalipoproteinemia]]'''
+:'''[[Primary hypertriglyceridemia]]'''
+:'''[[Mixed hyperlipoproteinemia]]'''
 |-
 !
@@ Line 27: / Line 44: @@
 |- bgcolor="Pink"
 !
-[[Hyperlipoproteinemia#Overview|Overview]]
+[[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]]
 |-
 !
@@ Line 33: / Line 50: @@
 |- bgcolor="Pink"
 !
-[[Hyperlipoproteinemia#Classification|Classification]]
+[[Hyperlipoproteinemia#Screening|Screening]]
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="CadetBlue"
 !
-[[Hyperlipoproteinemia#Synopsis|Synopsis]]
+'''ACC/AHA Guideline Recommendations'''
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="PaleTurquoise"
 !
-[[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]]
+[[ACC AHA guideline on summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults|Summary]]
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="PaleTurquoise"
 !
-[[Hyperlipoproteinemia#Diagnostic Algorithm|Diagnostic Algorithm]]
+[[ACC AHA guideline on the treatment of blood cholesterol|Treatment]]
 |-
 !
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Major recommendations for statin therapy]]
+|-
+!
-|- bgcolor="LightCoral"
+|- bgcolor="PaleTurquoise"
 !
-'''Primary Hyperlipoprotein Disorders:'''
+[[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy|Therapeutic response to statin therapy]]
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="PaleTurquoise"
 !
-:'''Type I - [[Familial hyperchylomycronemia]]'''
+[[ACC AHA guideline on the treatment of blood cholesterol LDL and non-HDL treatment goals|Blood cholesterol LDL and non-HDL treatment goals]]
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="PaleTurquoise"
 !
-:'''Type II'''
+[[ACC AHA guideline on the treatment of blood cholesterol heart failure and hemodialysis|Treatment in heart failure and hemodialysis]]
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="PaleTurquoise"
 !
-::'''Type IIA - [[Familial hypercholesterolemia]]'''
+[[ACC AHA guideline on the treatment of blood cholesterol primary prevention|Primary prevention]]
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="PaleTurquoise"
 !
-::'''Type IIB - [[Familial combined hyperlipidemia]]'''
+[[ACC AHA guideline on the treatment of blood cholesterol secondary prevention|Secondary prevention]]
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="PaleTurquoise"
 !
-:'''Type III - [[Dysbetalipoproteinemia]]'''
+[[ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention|Intensity of statin therapy in primary and secondary prevention]]
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="PaleTurquoise"
 !
-:'''Type IV - [[Primary hypertriglyceridemia]]'''
+[[ACC AHA guideline on the treatment of blood cholesterol safety|Safety Recommendations]]
 |-
 !
-|- bgcolor="Pink"
+|- bgcolor="PaleTurquoise"
 !
-:'''Type V - [[Mixed hyperlipoproteinemia]]'''
+[[Lifestyle Management to Reduce Cholestrol|Guideline on Lifestyle Management]]
 |-
 !
 |}

Template:Hyperlipoproteinemia: Difference between revisions

Latest revision as of 14:41, 3 March 2017

Navigation menu